WHICH TEST TO USE FOR DETERMINATION OF CLARITHROMYCIN AND LEVOFLOXACIN SUSCEPTIBILITY IN HELICOBACTER PYLORI INFECTION?

被引：0
|
作者：
Becerikli, T. [1 ]
Yilmaz, O. [1 ]
Demiray-Gurbuz, E. [1 ]
Soyturk, M. [2 ]
Ellidokuz, H. [3 ]
Simsek, I. [2 ]
机构：
[1] Dokuz Eylul Univ, Fac Med, Dept Med Microbiol, Izmir, Turkey
[2] Dokuz Eylul Univ, Fac Med, Dept Gastroenterol, Izmir, Turkey
[3] Dokuz Eylul Univ, Fac Med, Dept Biostat & Med Informat, Izmir, Turkey
来源：
HELICOBACTER | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P13.09
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [31] Clarithromycin resistance in Helicobacter pylori infection:: Does it matter?
    Fock, KM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (10) : 1089 - 1092
  • [32] Helicobacter pylori: Primary susceptibility to clarithromycin in vitro in Nova Scotia
    Best, LM
    Haldane, DJM
    Bezanson, GS
    vanZanten, SJOV
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 11 (04) : 298 - 300
  • [33] Which Therapy for Helicobacter pylori Infection?
    Graham, David Y.
    Shiotani, Akiko
    GASTROENTEROLOGY, 2012, 143 (01) : 10 - 12
  • [34] Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland
    Karczewska, Elzbieta
    Wojtas-Bonior, Izabela
    Sito, Edward
    Zwolinska-Wcislo, Malgorzata
    Budak, Alicja
    PHARMACOLOGICAL REPORTS, 2011, 63 (03) : 799 - 807
  • [35] PREVALENCE OF PRIMARY RESISTANCE OF HELICOBACTER PYLORI TO CLARITHROMYCIN (CLA) AND LEVOFLOXACIN (LF) IN SOUTHERN SPAIN
    Navarro-Jarabo, J.
    Fernandez-Sanchez, F.
    Fernandez-Moreno, N.
    Casado, F.
    Hervas, A.
    Pallares, H.
    Rodriguez, C.
    Puente, J.
    Perz-Aisa, A.
    Montiel, N.
    HELICOBACTER, 2013, 18 : 138 - 138
  • [36] Current Prevalence of Helicobacter pylori Resistance to Clarithromycin, Metronidazole, Amoxycillin, Tetracycline and Levofloxacin in Brazil
    Eisig, Jaime N.
    Navarro-Rodriguez, Tomas
    Barbuti, Ricardo C.
    Silva, Fernando M.
    Moraes-Filho, Joaquim P.
    Zaterka, Schlioma
    GASTROENTEROLOGY, 2009, 136 (05) : A342 - A343
  • [37] Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland
    Elżbieta Karczewska
    Izabela Wojtas-Bonior
    Edward Sito
    Małgorzata Zwolińska-Wcisło
    Alicja Budak
    Pharmacological Reports, 2011, 63 : 799 - 807
  • [38] Levofloxacin Susceptibility Testing for Helicobacter pylori in China: Comparison of E-Test and Disk Diffusion Method
    Yu, Chaohui
    Li, Lan
    Chen, Wenguo
    Jiao, Yangwen
    Yang, Ningmin
    Yang, En
    Zhang, Jianzhong
    Chen, Lihua
    Li, Youming
    HELICOBACTER, 2011, 16 (02) : 119 - 123
  • [39] Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection
    Zamani, M.
    Shokri-Shirvani, J.
    Zamani, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 572 - 573
  • [40] Determination of severity of Helicobacter pylori infection by use of a compartmental model
    Jung, A
    Wasilewska-Radwanska, M
    Kopanski, Z
    MEDICON 2001: PROCEEDINGS OF THE INTERNATIONAL FEDERATION FOR MEDICAL & BIOLOGICAL ENGINEERING, PTS 1 AND 2, 2001, : 955 - 956
12345